OOIR: Observatory of International Research

Papers

(The H4-Index of Chest is 55. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
General Information	644
Impact of the COVID-19 Pandemic on Volumes and Disparities in Lung Cancer Screening	307
Monitoring Biologic Therapy in Asthma Using Functional Imaging	269
Effect of Corticosteroids on Long-Term Humoral and Memory T-Cell Responses in Follow-Up Visit of Hospitalized Patients With COVID-19	254
Applying Noninvasive Ventilation in Treatment of Acute Exacerbation of COPD Using Evidence-Based Interprofessional Clinical Practice	215
Keep Gimmicks of Toy E-Cigarettes Away and Juveniles on Track Towards the Tobacco Endgame	196
Chronic Cough-Related Differences in Brain Morphometry in Adults	190
Intrafamilial Correlation and Variability in the Clinical Evolution of Pulmonary Fibrosis	164
General Information	162
General Information	150
Rebuttal From Drs Punjabi and Gottlieb	148
Table of Contents	126
Preprocedural COVID-19 Testing for High Risk Procedures	126
What Can Simulations Tell Us About Triage Protocols in a Real Pandemic?	118
Training POCUS	115
Response	100
Intrapleural Foreign Body in a Critically Ill Patient	96
Resilience in Health Care	90
A 49-Year-Old Woman With Persistent Bilateral Pleural Effusions	84
A 70-Year-Old Woman With Refractory Hypoxemia	83
General Information	81
Rebuttal From Dr Keir and Prof Chalmers	80
General Information	79
LACTOBACILLUS ENDOCARDITIS, A SINISTER CONSEQUENCE OF AN INNOCUOUS BACTERIUM	78
Response	78

A 36-Year-Old Patient With Crohn Disease and Bilateral Pleural Effusions	75
Comparison of Guidelines for Evaluation of Suspected Pulmonary Embolism in Pregnancy	75
“Suction vs Gravity: A Distinction Without a Difference?”	75
General Information	73
Implications of Global Lung Function Initiative Spirometry Reference Equations in Northeast Asian Patients With COPD	72
General Information	70
Cancer in Cystic Fibrosis	69
A 51-Year-Old Man With Dyspnea and a Pulmonary Nodule	69
Attic of Sorrow	69
The Proton Is Not Enough	69
REFRACTORY THROMBOTIC THROMBOCYTOPENIC PURPURA DUE TO COVID-19	66
BENIGN PLEURAL SCHWANNOMA WITH PLEURAL EFFUSIONS AND NECROTIZING PNEUMONIA	64
SCREENING QUESTIONS AS AN EFFECTIVE PREDICTOR OF SMOKING CESSATION SUCCESS IN A SMOKING CESSATION PILOT PROGRAM	64
CARDIAC TAMPONADE: BEYOND PERICARDIAL EFFUSION: A TALE OF TWO COMPRESSIVE MEDIASTINAL MASSES	64
STUDYING THE LINK BETWEEN IDIOPATHIC PULMONARY FIBROSIS AND GI REFLUX DISEASE: A NATIONWIDE PERSPECTIVE	64
A RARE CASE OF SPONTANEOUS PNEUMOMEDIASTINUM DURING SECOND TRIMESTER OF PREGNANCY	61
REPERFUSION PULMONARY EDEMA AFTER RESECTION OF A MALIGNANT SOLITARY FIBROUS TUMOR OF THE PLEURA MANAGED WITH VENOVENOUS EXTRACORPOREAL MEMBRANE OXYGENATION	61
AORTIC DISSECTION INDUCED BY PERSISTENT COUGHING IN A PATIENT WITH EMPHYSEMA	59
NONISCHEMIC CARDIOMYOPATHY PRESENTING WITH ABDOMINAL PAIN: AN INCIDENTAL LEFT VENTRICULAR THROMBUS	59
NONCARDIOGENIC PULMONARY EDEMA IN AN OBESE PATIENT DUE TO EXCESSIVE DYNAMIC AIRWAY COLLAPSE AND SEVERE OSA	59
VARIABILITY IN CENTRAL AND LOCAL MEASUREMENT OF FVC IN IDIOPATHIC PULMONARY FIBROSIS: AN EXPLORATORY ANALYSIS FROM THE CAPACITY, ASCEND, AND RIFF (COHORT A) TRIALS	59
PROLACTINOMA PRECEDING SPORADIC LYMPHANGIOLEIOMYOMATOSIS: A CASE REPORT	58
IMPORTANCE OF PATIENT THROUGHPUT WHEN SIMULATING CRISIS STANDARDS OF CARE: EXCLUSION CRITERIA AND TRIAGE SCORE MODIFIERS	57
THIS DYSPNEA FEELS DIFFERENT: A CASE OF DIFFERENTIATION SYNDROME	57
TOXIC TO THE LUNGS: A CASE OF DAPTOMYCIN-INDUCED ACUTE EOSINOPHILIC PNEUMONIA	57
HYDROCORTISONE, VITAMIN C, AND THIAMINE SUPPLEMENTATION VS PLACEBO IN PATIENTS WITH SEPSIS	57
WITHDRAWN	57
AN UNUSUAL CAUSE OF RECURRENT PNEUMONIAS	56
A RARE CASE OF PACEMAKER LEAD-ASSOCIATED THROMBOSIS IN AN ANTICOAGULATED PATIENT	55
NEW REFERENCE EQUATIONS FOR IMPULSE OSCILLOMETRY	55
CHRONIC MYELOID LEUKEMIA COMPLICATED WITH BILATERAL PLEURAL EFFUSIONS SECONDARY TO BOSUTINIB	55